DOI QR코드

DOI QR Code

Comparison of Severe Disease Incidence among Eligible Insureds to Expand Coverage for Substandard Risks

유병자 보험의 보장성 확대를 위한 유병자들의 중증질환 발생률 비교

  • Baek, Hyeyoun (Department of Population Policy Research, Center for Population Impact Assessment, Korea Institute for Health and Social Affairs) ;
  • Son, Jihoon (Department of Mathematics, Sungkyunkwan University) ;
  • Shin, Jimin (Department of Actuarial Science, Sungkyunkwan University)
  • 백혜연 (한국보건사회연구원) ;
  • 손지훈 (성균관대학교 수학과) ;
  • 신지민 (성균관대학교 보험계리학과)
  • Received : 2018.10.18
  • Accepted : 2018.11.19
  • Published : 2018.11.30

Abstract

Objectives: People are living longer, but often with diseases or chronic conditions. As a consequence, interest in resolving insurance blind spots is growing. This study provides substandard risk-relevant statistics to help substandard risks who are likely to fall in insurance blind spots obtain insurance coverage, such as the reimbursement of medical costs, as well as to stimulate insurance product development. Methods: This study uses National Health Insurance Service (NHIS) cohort data to determine the relevant statistics. The incidence rates of severe diseases are derived and compared against standard risks to establish a set of relative risk factors. These incidence rates of standard and substandard risks are then compared. Results: Currently, an individual's cancer history is used in the underwriting process for simplified issue insurance. However, underwriting focusing on hospitalization and procedures related to serious illnesses could lower premiums for substandard risks. Moreover, the statistical results could be used to expand the coverage of health insurance products. Conclusions: This study's relative risk factors can be used to derive simplified issue premium rates for substandard risks. They can also be used to implement discount and loading schemes for medical reimbursement insurance and help insurance companies implement proactive risk management.

Keywords

Acknowledgement

Supported by : National Health Insurance Service (NHIS)

Cited by

  1. A Randomized, Double-Blind, Placebo-Controlled, Multi-Centered Clinical Study to Evaluate the Efficacy and Safety of Artemisia annua L. Extract for Improvement of Liver Function vol.9, pp.4, 2018, https://doi.org/10.7762/cnr.2020.9.4.258